This BCC Research report provides an overview of the current and future states of the RNA Sequencing (RNA Seq) market for the years 2015, 2016 and 2020 in segments such as instruments, tools and reagents, data analysis, and services.
Use this report to:
Analyze various segments of the RNA-Sequencing market such as RNA-Sequencing tools and reagents, RNA-Sequencing data analysis, and RNA-Sequencing services Identify the main factors affecting each segment and forecast their market growth, future trends and product development Evaluate infrastructure for the health and growth of the RNA-Sequencing market as a whole
The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8 million in 2015, a CAGR of 13.0%. The services segment should reach $460.5 million by 2020 from $170.5 million in 2015, a CAGR of 9.1%.
STUDY GOALS AND OBJECTIVES
This BCC Research report, RNA Sequencing: Technologies and Global Markets, provides an overview of the current and future states of the RNA Sequencing (RNA-Seq) market for the years 2015, 2016 and 2020 in the following segments: instruments, tools and reagents, data analysis, and services. Special emphasis is placed on RNA-Seq technology development because RNA-Seq depends on the development of new and improved high throughput sequencing technologies.
This report describes the available technologies and the major players currently working in the market, as well as detailed analysis of the competitive environments, including new or potential trends in research and product development. This report also includes information regarding opportunities and obstacles affecting this market and its different sectors.
Each of the four RNA-Seq segments has healthy growth potential. Each of them also face serious and unique challenges. This report has a comprehensive discussion of technologies as well as the competitive landscape in the global market. It is designed to aim companies in their strategic planning efforts for exploiting RNA-Seq industry opportunities.
REASONS FOR DOING THE STUDY
RNA-Seq, introduced around 2010, is a method for transcriptomics. In a few short years, it has become the method of choice for transcriptome studies, rapidly replacing another transcriptomics method; the microarray. Transcriptomics is the study of transcriptome, the complete set of RNA transcripts that are produced by the genome, under specific circumstances or in a specific cell, using high-throughput methods.
RNA-Seq not only provides benefits to the scientific research community, but also has huge clinical potential in diagnostics and drug discovery. The RNA-Seq industry is an emerging, evolving and important biomedical sector; a comprehensive and critical study about its technologies and markets is needed for better understanding.
SCOPE AND FORMAT
The geographic scope is global. The RNA-Seq market is complex, consisting of a number of different segments. The market segments are: RNA-Seq instruments; RNA-Seq tools and reagents; RNA-Seq data analysis and RNA-Seq services. Each segment is affected differently by technological and regulatory developments. This report identifies the main factors affecting each segment and forecasts market growth, future trends and product development in every major market segment. Market forecasts are given for the years 2015, 2016 and 2020.
The report is organized by presenting the core segment (sequencing instruments) first, followed by its derivative segments (tools and reagents, data analysis, services). The development of sequencing instruments is vital for RNA-Seq development; thus sequencing instruments segment is classified as the core segment. However, it does not suggest that the derivative segments are not important. In fact, the RNA-Seq instruments segment is neither the biggest nor the fastest growing among the four segments. The instruments segment, however, provides the infrastructure for the health and growth of the RNA-Seq market as a whole.
Our reports have been used by over 10K customers, including:
178 pages •
By Global Industry Analysts
• Apr 2021
- Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis...
168 pages •
By Global Industry Analysts
• Apr 2021
- Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
Spatial Genomics & Transcriptomics Market Report Overview Spatial Genomics & Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Spatial Genomics & Transcriptomics market types and applications. It is a focused study on...
Transcriptomics Market Report Overview Transcriptomics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Transcriptomics market types and applications. It is a focused study on Transcriptomics market space including global and regional...
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030 Market Report Coverage - Spatial Genomics and Transcriptomics Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
23andMe, Inc - Tech Innovator Profile
23andMe, Inc. (23andMe) is a personal genomics and biotechnology company that leverages machine learning (ML) technology to provide DNA analysis services.
The report provides information and insights into 23andMe, Inc.’s, including...
This study covers the world outlook for ribonucleic acid (RNA) analysis and transcriptomics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and...
187 pages •
By Global Industry Analysts
• Oct 2019
Transcriptomics market worldwide is projected to grow by US$6 Billion, driven by a compounded growth of 13.9%. Microarray, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.